Tag: AbbVie

May 5, 2020

AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL

Health Canada has approved AbbVie's VENCLEXTA in combination with obinutuzumab to treat adult patients with previously untreated CLL.
April 17, 2020

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
January 27, 2020

Pharma Companies Scramble to Address Coronavirus

With concern growing about the novel coronavirus, pharmaceutical firms are jumping to try to keep up with the quickly spreading...
January 16, 2020

Investing in Pharmaceutical Companies: What You Need to Know

Pharmaceutical companies work towards bringing new cures to the market and improving treatments available for patients.
December 23, 2019

Pharma Trends 2019: FDA Approvals Make Waves Through Market

INN takes a look at the pharma trends of 2019 that have shaken up the space this year and created...
December 12, 2019

Biotech Trends 2019: M&A Slows, CNS Therapies Make Headlines

2019 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...